HeartBeam, Inc. 8-K

What Happened
HeartBeam, Inc. (BEAT) announced in an 8-K that on June 30, 2026 it received a deficiency letter from Nasdaq notifying the company that its common stock failed to meet the Nasdaq Capital Market minimum bid price requirement of $1.00 per share. The company’s listing remains active, and Nasdaq has given HeartBeam a 180-calendar-day compliance period ending December 28, 2026 to get the closing bid price back to at least $1.00.

Key Details

• Notice date: June 30, 2026; deficiency based on the last 30 consecutive business days of closing bids.
• Compliance window: 180 days from the notice (deadline December 28, 2026).
• To regain compliance: closing bid must be $1.00 or higher for at least 10 consecutive business days before December 28, 2026.
• If not compliant by that date, HeartBeam may be eligible for a second 180-day period only if it meets Nasdaq’s market value of publicly held shares and other initial listing standards (except the minimum bid price). The company can appeal any delisting determination to a Nasdaq hearings panel.

Why It Matters
A continued failure to meet Nasdaq’s $1.00 minimum bid price could lead to delisting, which can reduce liquidity, limit investor access, and harm the stock’s marketability. HeartBeam’s listing is currently unaffected while the company tries to regain compliance, but there is no assurance it will succeed or obtain an additional cure period. Investors should monitor the company’s stock price, any steps management announces to regain compliance, and subsequent filings for updates.